Quote | Exagen Inc. (NYSE:XGN)
Last: | $ |
---|---|
Change Percent: | -0.50% |
Open: | $18.20 |
Close: | $18.04 |
High: | $18.77 |
Low: | $17.605 |
Volume: | 215,638 |
Last Trade Date Time: | 02/12/2020 04:43:42 pm |
News | Exagen Inc. (NYSE:XGN)
2024-03-18 13:23:06 ET Exagen Inc. (XGN) Q4 2023 Earnings Conference Call March 18, 2024, 8:30 a.m. ET Company Participants John Aballi - President and CEO Kamal Adawi - CFO Ryan Douglas - IR Conference Call Participants Mark Massaro - BTIG Kyle M...
2024-03-18 11:27:21 ET More on Exagen Exagen reaffirms FY23 revenue of at least $50M Seeking Alpha’s Quant Rating on Exagen Historical earnings data for Exagen Financial information for Exagen Read the full article on Seeking Alpha For ...
Message Board Posts | Exagen Inc. (NYSE:XGN)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Exagen Inc. Company Name:
XGN Stock Symbol:
NYSE Market:
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2023. Financial Highlights: Record total revenue of $52...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announc...